Protective effect of parecoxib sodium against ischemia reperfusion‑induced intestinal injury

Li,Mei; Zheng,Zhi

doi:10.3892/mmr.2021.12416

Protective effect of parecoxib sodium against ischemia reperfusion‑induced intestinal injury

Authors:
- Mei Li
- Zhi Zheng
View Affiliations

Affiliations: Department of Anesthesiology, Huangyan Hospital Affiliated to Wenzhou Medical University, Taizhou First People's Hospital, Taizhou, Zhejiang 318020, P.R. China
Published online on: September 7, 2021 https://doi.org/10.3892/mmr.2021.12416
Article Number: 776
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Ischemia reperfusion (I/R)‑induced intestinal injury is a pathophysiological process leading to oxidative stress and inflammatory responses, and revealing its underlying mechanisms is essential for developing therapeutic strategies. Cyclooxygenase (COX) has been reported to be involved in I/R injury. Parecoxib sodium, a selective inhibitor for COX‑2, exerts protective effects, such as reducing I/R‑induced injuries in the heart, kidney and brain. However, the potential role of parecoxib sodium in protecting the small intestine against I/R‑induced injury has rarely been investigated. Therefore, the aim of the present study was to elucidate the effects and potential mechanisms of parecoxib sodium in I/R‑induced intestinal injury. In total, 60 Sprague‑Dawley rats were randomly divided into four groups: Control (sham operation) group, intestinal I/R group, 10 mg/kg parecoxib sodium‑pre‑treated I/R (I/R + Pare/10) group and the 20 mg/kg parecoxib sodium‑pre‑treated I/R (I/R + Pare/20) group. A regular I/R model was established to induce the intestinal injury in rats. Parecoxib sodium at 10 or 20 mg/kg was intraperitoneally administered into rats in both I/R + Pare groups once daily for 5 consecutive days prior to ischemia. Blood samples and small intestinal tissues were collected at 2 h after reperfusion. Changes in the levels of malondialdehyde, nitric oxide, interleukin (IL)‑1β, IL‑8, intercellular cell adhesion molecule‑1 and IL‑10, as well as the total antioxidant capacity were determined using ELISA, as were the activities of superoxidase dismutase and myeloperoxidase. Furthermore, the protein expression levels of total caspase‑3, cleaved caspase‑3, Bcl‑2 and Bax were examined via western blot analysis. In addition, the daily survival rate post‑reperfusion was examined for 7 days. It was revealed that parecoxib sodium increased the levels of antioxidants and suppressed the intestinal oxidative injury induced by I/R. Moreover, parecoxib sodium downregulated the expression levels of the proinflammatory factors, but upregulated the expression levels of anti‑inflammatory factors. The results also demonstrated that parecoxib sodium attenuated I/R‑induced apoptosis and increased the survival rate of rats. Thus, administration of parecoxib sodium prior to intestinal I/R attenuated intestinal injury and increased the rat survival rate by inhibiting I/R‑induced inflammation, oxidative stress and apoptosis.

View Figures

View References

1	Kalogeris T, Baines CP, Krenz M and Korthuis RJ: Ischemia/reperfusion. Compr Physiol. 7:113–170. 2016. View Article : Google Scholar : PubMed/NCBI
2	Mandalaneni K, Rayi A and Jillella DV: Stroke reperfusion injury. StatPearls [Internet] Treasure Island (FL): StatPearls Publishing; 2021, https://www.ncbi.nlm.nih.gov/books/NBK564350/
3	Guneli E, Cavdar Z, Islekel H, Sarioglu S, Erbayraktar S, Kiray M, Sokmen S, Yilmaz O and Gokmen N: Erythropoietin protects the intestine against ischemia/reperfusion injury in rats. Mol Med. 13:509–517. 2007. View Article : Google Scholar : PubMed/NCBI
4	Tahir M, Arshid S, Fontes B, Castro MS, Luz IS, Botelho KLR, Sidoli S, Schwämmle V, Roepstorff P and Fontes W: Analysis of the effect of intestinal ischemia and reperfusion on the rat neutrophils proteome. Front Mol Biosci. 5:892018. View Article : Google Scholar : PubMed/NCBI
5	Lenaerts K, Ceulemans LJ, Hundscheid IH, Grootjans J, Dejong CH and Olde Damink SW: New insights in intestinal ischemia-reperfusion injury: Implications for intestinal transplantation. Curr Opin Organ Transplant. 18:298–303. 2013. View Article : Google Scholar : PubMed/NCBI
6	Liu DM, Sun BW, Sun ZW, Jin Q, Sun Y and Chen X: Suppression of inflammatory cytokine production and oxidative stress by CO-releasing molecules-liberated CO in the small intestine of thermally-injured mice. Acta Pharmacol Sin. 29:838–846. 2008. View Article : Google Scholar : PubMed/NCBI
7	Farmer DG, Ke B, Shen XD, Kaldas FM, Gao F, Watson MJ, Busuttil RW and Kupiec-Weglinski JW: Interleukin-13 protects mouse intestine from ischemia and reperfusion injury through regulation of innate and adaptive immunity. Transplantation. 91:737–743. 2011. View Article : Google Scholar : PubMed/NCBI
8	Arndt H, Kubes P and Granger DN: Involvement of neutrophils in ischemia-reperfusion injury in the small intestine. Klin Wochenschr. 69:1056–1060. 1991. View Article : Google Scholar : PubMed/NCBI
9	Ucar BI, Erikci A, Kosemehmetoglu K, Ozkul C, Iskit AB, Ucar G and Zeren S: Effects of endothelin receptor blockade and COX inhibition on intestinal I/R injury in a rat model: Experimental research. Int J Surg. 83:89–97. 2020. View Article : Google Scholar : PubMed/NCBI
10	Tóth Š, Jonecová Z, Čurgali K, Maretta M, Šoltés J, Švaňa M, Kalpadikis T, Caprnda M, Adamek M, Rodrigo L and Kruzliak P: Quercetin attenuates the ischemia reperfusion induced COX-2 and MPO expression in the small intestine mucosa. Biomed Pharmacother. 95:346–354. 2017. View Article : Google Scholar : PubMed/NCBI
11	Smith WL: A seven-step plan for becoming a moderately rich and famous biochemist. J Biol Chem. 294:1779–1793. 2019. View Article : Google Scholar : PubMed/NCBI
12	Singh R, Kumar R and Singh DP: Nitric oxide-releasing nonsteroidal anti-inflammatory drugs: Gastrointestinal-sparing potential drugs. J Med Food. 12:208–218. 2009. View Article : Google Scholar : PubMed/NCBI
13	Takeuchi K and Amagase K: Roles of cyclooxygenase, prostaglandin E2 and EP receptors in mucosal protection and ulcer healing in the gastrointestinal tract. Curr Pharm Des. 24:2002–2011. 2018. View Article : Google Scholar : PubMed/NCBI
14	Zhu L, Xu C, Huo X, Hao H, Wan Q, Chen H, Zhang X, Breyer RM, Huang Y, Cao X, et al: The cyclooxygenase-1/mPGES-1/endothelial prostaglandin EP4 receptor pathway constrains myocardial ischemia-reperfusion injury. Nat Commun. 10:18882019. View Article : Google Scholar : PubMed/NCBI
15	Chen Y, Wang JC, Yang CM, Fan Q, Zheng J and Liu H: Positive acceleration adaptive training attenuates gastric ischemia-reperfusion injury through COX-2 and PGE2 expression. Exp Ther Med. 17:2901–2906. 2019.PubMed/NCBI
16	Hamada T, Tsuchihashi S, Avanesyan A, Duarte S, Moore C, Busuttil RW and Coito AJ: Cyclooxygenase-2 deficiency enhances Th2 immune responses and impairs neutrophil recruitment in hepatic ischemia/reperfusion injury. J Immunol. 180:1843–1853. 2008. View Article : Google Scholar : PubMed/NCBI
17	Zhang T, Ma Y, Xu KQ and Huang WQ: Pretreatment of parecoxib attenuates hepatic ischemia/reperfusion injury in rats. BMC Anesthesiol. 15:1652015. View Article : Google Scholar : PubMed/NCBI
18	Liu S, Dai Y, Zhou C and Zhu T: Parecoxib exhibits anti-inflammatory and neuroprotective effects in a rat model of transient global cerebral ischemia. J Toxicol Environ Health A. 83:203–214. 2020. View Article : Google Scholar : PubMed/NCBI
19	Patel NS, Cuzzocrea S, Collino M, Chaterjee PK, Mazzon E, Britti D, Yaqoob MM and Thiemermann C: The role of cycloxygenase-2 in the rodent kidney following ischaemia/reperfusion injury in vivo. Eur J Pharmacol. 562:148–154. 2007. View Article : Google Scholar : PubMed/NCBI
20	Kamel MY, Ahmed SM and Abdelzaher WY: The potential protective effect of modafinil in intestinal ischemic reperfusion-induced in rats. Int Immunopharmacol. 88:1069832020. View Article : Google Scholar : PubMed/NCBI
21	Boivin GP, Hickman DL, Creamer-Hente MA, Pritchett-Corning KR and Bratcher NA: Review of CO2 as a euthanasia agent for laboratory rats and mice. J Am Assoc Lab Anim Sci. 56:491–499. 2017.PubMed/NCBI
22	Tong F, Dong B, Chai R, Tong K, Wang Y, Chen S, Zhou X and Liu D: Simvastatin nanoparticles attenuated intestinal ischemia/reperfusion injury by downregulating BMP4/COX-2 pathway in rats. Int J Nanomedicine. 12:2477–2488. 2017. View Article : Google Scholar : PubMed/NCBI
23	Kamel M, Ahmed SM and Abdelzaher W: The potential protective effect of modafinil in intestinal ischemic reperfusion-induced in rats. Int Immunopharmacol. 88:1069832020. View Article : Google Scholar : PubMed/NCBI
24	Duarte S, Kato H, Kuriyama N, Suko K, Ishikawa TO, Busuttil RW, Herschman HR and Coito AJ: Hepatic ischemia and reperfusion injury in the absence of myeloid cell-derived COX-2 in mice. PLoS One. 9:e969132014. View Article : Google Scholar : PubMed/NCBI
25	Feng Y, Ju H, Yang B and An H: Effects of a selective cyclooxygenase-2 inhibitor on postoperative inflammatory reaction and pain after total knee replacement. J Pain. 9:45–52. 2008. View Article : Google Scholar : PubMed/NCBI
26	Öztürk T, Vural K, Tuğlu İ, Var A, Kurdal T and Aydemir I: Acute and chronic pretreatment with atenolol attenuates intestinal ischemia and reperfusion injury in hypercholesterolemic rats. J Cardiothorac Vasc Anesth. 30:985–992. 2016. View Article : Google Scholar : PubMed/NCBI
27	Habes QLM, Linssen V, Nooijen S, Kiers D, Gerretsen J, Pickkers P, Scheffer GJ and Kox M: Markers of intestinal damage and their relation to cytokine levels in cardiac surgery patients. Shock. 47:709–714. 2017. View Article : Google Scholar : PubMed/NCBI
28	Li Q, Ye T, Long T and Peng X: Ginkgetin exerts anti-inflammatory effects on cerebral ischemia/reperfusion-induced injury in a rat model via the TLR4/NF-kB signaling pathway. Biosci Biotechnol Biochem. 83:675–683. 2019. View Article : Google Scholar : PubMed/NCBI
29	Vollmar B and Menger MD: Intestinal ischemia/reperfusion: Microcirculatory pathology and functional consequences. Langenbecks Arch Surg. 396:13–29. 2011. View Article : Google Scholar : PubMed/NCBI
30	Stichtenoth DO: The second generation of COX-2 inhibitors: Clinical pharmacological point of view. Mini Rev Med Chem. 4:617–624. 2004. View Article : Google Scholar : PubMed/NCBI
31	Tyvold SS, Solligård E, Gunnes S, Lyng O, Johannisson A, Grønbech JE and Aadahl P: Bronchial microdialysis of cytokines in the epithelial lining fluid in experimental intestinal ischemia and reperfusion before onset of manifest lung injury. Shock. 34:517–524. 2010. View Article : Google Scholar : PubMed/NCBI
32	Wang GJ, Deng HY, Maier CM, Sun GH and Yenari MA: Mild hypothermia reduces ICAM-1 expression, neutrophil infiltration and microglia/monocyte accumulation following experimental stroke. Neuroscience. 114:1081–1090. 2002. View Article : Google Scholar : PubMed/NCBI
33	Sun Y, Xu Q, Wu Z, Gong Y and Tang L: Parecoxib inhibits inflammatory responses in a mouse model of sepsis. FEBS Open Bio. Apr 3–2020.(Epub ahead of print). View Article : Google Scholar
34	Kimura M, Yokoyama A and Higuchi S: Aldehyde dehydrogenase-2 as a therapeutic target. Expert Opin Ther Targets. 23:955–966. 2019. View Article : Google Scholar : PubMed/NCBI
35	Wallace JL, Ianaro A and de Nucci G: Gaseous mediators in gastrointestinal mucosal defense and injury. Dig Dis Sci. 62:2223–2230. 2017. View Article : Google Scholar : PubMed/NCBI
36	Lau A, Arundine M, Sun HS, Jones M and Tymianski M: Inhibition of caspase-mediated apoptosis by peroxynitrite in traumatic brain injury. J Neurosci. 26:11540–11553. 2006. View Article : Google Scholar : PubMed/NCBI
37	Liu W, Fan Z, Han Y, Lu S, Zhang D, Bai X, Xu W, Li J and Wang H: Curcumin attenuates peroxynitrite-induced neurotoxicity in spiral ganglion neurons. Neurotoxicology. 32:150–157. 2011. View Article : Google Scholar : PubMed/NCBI
38	Borisov VB, Siletsky SA, Nastasi MR and Forte E: ROS defense systems and terminal oxidases in bacteria. Antioxidants (Basel). 10:8392021. View Article : Google Scholar : PubMed/NCBI
39	Pérez S, Taléns-Visconti R, Rius-Pérez S, Finamor I and Sastre J: Redox signaling in the gastrointestinal tract. Free Radic Biol Med. 104:75–103. 2017. View Article : Google Scholar : PubMed/NCBI
40	Wu F, Wang W, Duan Y, Guo J, Li G and Ma T: Effect of parecoxib sodium on myocardial ischemia-reperfusion injury rats. Med Sci Monit. 27:e9282052021.PubMed/NCBI
41	Luo CC, Huang CS, Ming YC, Chu SM and Chao HC: Calcitonin gene-related peptide downregulates expression of inducible nitride oxide synthase and caspase-3 after intestinal ischemia-reperfusion injury in rats. Pediatr Neonatol. 57:474–479. 2016. View Article : Google Scholar : PubMed/NCBI